NCT04799275 2026-03-19Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell LymphomaNational Cancer Institute (NCI)Phase 2/3 Suspended422 enrolled